BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27601842)

  • 1. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Burkitt's lymphoma: A case report and review.
    Chettiankandy TJ; Tupkari JV; Kumar K; Ahire MS
    J Oral Maxillofac Pathol; 2016; 20(2):333. PubMed ID: 27601842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases.
    Gualco G; Natkunam Y; Bacchi CE
    Mod Pathol; 2012 May; 25(5):661-74. PubMed ID: 22222636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYC Negative Rectal B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Burkitt's Lymphoma in an Immunocompetent Patient.
    Parikh JG; Strom T; Stone I
    Case Rep Pathol; 2013; 2013():302304. PubMed ID: 23365776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gray zone lymphomas in pediatric patients.
    Liang X; Greffe B; Cook B; Giller R; Graham DK; McGranahan AN; Wang M
    Pediatr Dev Pathol; 2011; 14(1):57-63. PubMed ID: 20331368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological Analysis of B Cell Lymphomas, Unclassifiable; with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma in a Tertiary Care Hospital in Southern India.
    Selvi SK; Kar R; Basu D; Jacob SE; Dubashi B
    Indian J Hematol Blood Transfus; 2016 Jun; 32(2):168-75. PubMed ID: 27065578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [B-cell lymphoma, unclassifiable, intermediate between diffuse large B-cell lymphoma and Burkitt's lymphoma].
    Baryakh EA; Misyurina AE; Kovrigina AM; Misyurin VA; Kravchenko SK
    Ter Arkh; 2015; 87(4):91-97. PubMed ID: 26087641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGH amplification in patients with B cell lymphoma unclassifiable, with features intermediate between diffuse large B cell lymphoma and Burkitt's lymphoma.
    Bellone M; Zaslav AL; Ahmed T; Lee HL; Ma Y; Hu Y
    Biomark Res; 2014; 2():9. PubMed ID: 24891940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective.
    Salaverria I; Siebert R
    J Clin Oncol; 2011 May; 29(14):1835-43. PubMed ID: 21482997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
    Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burkitt's Lymphoma and B-Cell Lymphoma Unclassifiable With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt's Lymphoma in Patients With HIV: Outcomes in a South African Public Hospital.
    Sissolak G; Seftel M; Uldrick TS; Esterhuizen TM; Mohamed N; Kotze D
    J Glob Oncol; 2017 Jun; 3(3):218-226. PubMed ID: 28717763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary splenic B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A case report.
    Shi F; Zhou Q; Gao Y; Cui XQ; Chang H
    Oncol Lett; 2016 Sep; 12(3):1925-1928. PubMed ID: 27602118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.
    Bürgesser MV; Gualco G; Diller A; Natkunam Y; Bacchi CE
    Ann Diagn Pathol; 2013 Jun; 17(3):250-5. PubMed ID: 23246412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology consultation on intermediate-to-large B-cell lymphomas.
    Montgomery ND; Fedoriw Y
    Am J Clin Pathol; 2014 Mar; 141(3):305-17. PubMed ID: 24515757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of Burkitt Lymphoma and Related High-Grade B-Cell Neoplasms.
    Sohani AR; Hasserjian RP
    Surg Pathol Clin; 2010 Dec; 3(4):1035-59. PubMed ID: 26839298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.
    Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK
    Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology.
    Carbone A; Gloghini A; Aiello A; Testi A; Cabras A
    Hum Pathol; 2010 May; 41(5):621-31. PubMed ID: 20398809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary on the WHO classification of tumors of lymphoid tissues (2008): "Gray zone" lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma.
    Hasserjian RP; Ott G; Elenitoba-Johnson KS; Balague-Ponz O; de Jong D; de Leval L
    J Hematop; 2009 Jul; 2(2):89-95. PubMed ID: 19669187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach.
    Bellan C; Stefano L; Giulia de F; Rogena EA; Lorenzo L
    Hematol Oncol; 2010 Jun; 28(2):53-6. PubMed ID: 19844983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double hit lymphoma - a case of unusual response after sequential aggressive chemotherapy and review of the literature.
    Cheema FN; Agloria M; Koshy N; Hildebrandt GC
    Clin Med Insights Case Rep; 2014; 7():117-21. PubMed ID: 25336995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
    Hummel M; Bentink S; Berger H; Klapper W; Wessendorf S; Barth TF; Bernd HW; Cogliatti SB; Dierlamm J; Feller AC; Hansmann ML; Haralambieva E; Harder L; Hasenclever D; Kühn M; Lenze D; Lichter P; Martin-Subero JI; Möller P; Müller-Hermelink HK; Ott G; Parwaresch RM; Pott C; Rosenwald A; Rosolowski M; Schwaenen C; Stürzenhofecker B; Szczepanowski M; Trautmann H; Wacker HH; Spang R; Loeffler M; Trümper L; Stein H; Siebert R;
    N Engl J Med; 2006 Jun; 354(23):2419-30. PubMed ID: 16760442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.